產(chǎn)品名稱 |
Influenza B virus |
商品貨號 |
B223731 |
Classification |
Orthomyxoviridae, Influenzavirus B |
Agent |
Influenza B virus |
Strain |
B/Lee/40 |
Applications |
Influenza Research |
Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Product Format |
frozen 1 mL per vial |
Storage Conditions |
-70°C or colder |
Images |
|
Comments |
Derived by adaptation of egg allantoic fluid product ATCC VR-101 to MDCK cells (ATCC CCL-34). ATCC VR-101 and ATCC VR-1535 have not been compared for sequence or infectivity in eggs and tissue culture. |
Effect on Host |
CPE, rounding and sloughing |
Recommended Host |
MDCK (ATCC® CCL-34™) |
Growth Conditions |
Temperature: 37°C
Recommendations For Infection: Plate cells 24-48 hours prior to infection and infect when cultures are 80-90% confluent. Remove medium and inoculate with a small volume of virus (e.g. 1 mL per 25 cm 2) diluted to provide an optimal MOI (e.g. 0.01). Adsorb 1-2 hours at 37°C in a humidified 5% CO 2 atmosphere, rocking every 20-30 minutes to redistribute inoculum. End adsorption by adding virus growth medium.
Incubation: 1-4 days
|
Name of Depositor |
MT Coleman, Centers for Disease Control and Prevention |
Special Collection |
NCRR Contract |
Source |
Throat washings from an influenza patient, Irvington, New York, 1940 |
References |
Andrewes CH, et al. A short description of the Myxovirus group (Influenza and related viruses). Virology 1: 176-184, 1955. PubMed: 13267985
Francis T Jr. A new type of virus from epidemic influenza. Science 92: 405-408, 1940. PubMed: 17794275
|